Sign up for free insights newsletter
20

China National Accord Medicines Corp Ltd

200028SHE

Need professional-grade analysis? Visit stockanalysis.com

HK$13.45
+0.52%
End of day
Market Cap

$14.81B

P/E Ratio

N/A

Employees

N/A

Dividend Yield

299.00%

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-0.290.021.330.49
Calmar-0.540.031.540.52
Sharpe-0.230.011.020.37
Omega0.951.011.261.10
Martin-1.870.064.981.63
Ulcer1.422.503.182.51

China National Accord Medicines Corp Ltd (200028) Price Performance

China National Accord Medicines Corp Ltd (200028) trades on SHE in HKD. The company is classified in the Healthcare sector under the Medical Distribution industry. The stock currently trades at HKD13.45, up 0.52% from the previous close.

Over the past year, 200028 has traded between a low of HKD10.63 and a high of HKD14.07. The stock has gained 15.6% over this period. It is currently 26.5% above its 52-week low.

China National Accord Medicines Corp Ltd has a market capitalization of $14.81B and a dividend yield of 299.00%.

About China National Accord Medicines Corp Ltd

China National Accord Medicines Corporation Ltd. engages in the retail and distribution of pharmaceutical products in China and internationally. The company offers prescription drugs for various illnesses and medications requiring long-term use, such as oncology, liver disease, neurology, psychiatry, cardiovascular, and rheumatology/immunology. It also provides traditional Chinese medicine, Western medicine, rehabilitation therapy, and various medical-related resources through retail and medical service stores, as well as chemical drugs, OTC drugs, and health products. The company was formerly known as Shenzhen Health Mineral Water Corp., Ltd. China National Accord Medicines Corporation Ltd. was incorporated in 1993 and is headquartered in Shenzhen, China. China National Accord Medicines Corporation Ltd. operates as a subsidiary of Sinopharm Group Co., Ltd.

Company Info

Exchange
SHE
Currency
HKD
Country
China

Financial Metrics

Revenue (TTM)
$73.04B
EBITDA
$840.88M
Profit Margin
0.73%
EPS (TTM)
1.09
Book Value
37.67

Technical Indicators

52 Week High
HK$14.09
52 Week Low
HK$9.83
50 Day MA
HK$13.73
200 Day MA
HK$13.34
Beta
0.31

Valuation

Trailing P/E
12.28
Forward P/E
4.42
Price/Sales
0.20
Price/Book
0.36
Enterprise Value
$10.31B